Tuune, a London, UK-based femtech startup focused on women’s health, closed a $4.6M funding round.
The round was led by Octopus Ventures.
The company intends to use the funds to launch in the U.S. market.
Led by Shardi Nahavandi, Tuune offers individualized hormonal analysis and birth control. Clinicians use its proprietary technology to provide unbiased insights and recommendations of the best birth control for women, based on a comprehensive health history, lifestyle preferences, and hormone analysis. This individualized approach helps women alleviate their hormonal symptoms and conditions, including endometriosis, anxiety, weight gain, and acne.
THe company’s team includes leading experts in precision medicine, science and engineering, and is backed by prominent organizations including Google for Startups.
FinSMEs
11/10/2021